Results 211 to 220 of about 25,326 (255)
Some of the next articles are maybe not open access.
Ophthalmology, 2004
To determine the proportion of nondiagnosed uveal melanomas after evaluation by optometrists or ophthalmologists.Retrospective observational cohort study.Four hundred thirty-three ophthalmic oncology patients with uveal melanoma.This was a retrospective study of uveal melanoma patients from a single ophthalmic oncology center. We sent questionnaires to
Riley, Bove, Devron H, Char
openaire +2 more sources
To determine the proportion of nondiagnosed uveal melanomas after evaluation by optometrists or ophthalmologists.Retrospective observational cohort study.Four hundred thirty-three ophthalmic oncology patients with uveal melanoma.This was a retrospective study of uveal melanoma patients from a single ophthalmic oncology center. We sent questionnaires to
Riley, Bove, Devron H, Char
openaire +2 more sources
Current Opinion in Ophthalmology, 2022
Purpose of review This article reviews the latest proteomic research on uveal melanoma. Recent findings Proteomic analysis of uveal melanoma cell lines and tissue specimens has improved our understanding of the pathophysiology of uveal melanoma and helped identify potential ...
Michael J, Heiferman +2 more
openaire +2 more sources
Purpose of review This article reviews the latest proteomic research on uveal melanoma. Recent findings Proteomic analysis of uveal melanoma cell lines and tissue specimens has improved our understanding of the pathophysiology of uveal melanoma and helped identify potential ...
Michael J, Heiferman +2 more
openaire +2 more sources
Ophthalmology Clinics of North America, 2005
Despite achieving great accuracy in correctly diagnosing uveal melanoma in the United States, mortality owing to this tumor has remained unchanged over a period of 25 years from 1973 to 1997. In general, the survival with metastatic uveal melanoma is poor, with a median survival of less than 6 months.
Arun D, Singh, Ernest C, Borden
openaire +2 more sources
Despite achieving great accuracy in correctly diagnosing uveal melanoma in the United States, mortality owing to this tumor has remained unchanged over a period of 25 years from 1973 to 1997. In general, the survival with metastatic uveal melanoma is poor, with a median survival of less than 6 months.
Arun D, Singh, Ernest C, Borden
openaire +2 more sources
British Journal of Ophthalmology, 2008
We agree with the authors’ recommendation on the need for a sleep history in the eye clinic and probably having a lower threshold for referral to sleep physicians for further sleep studies.1 However, we would like to bring to their attention other epidemiological studies where screening tools/sleep history have shown a high prevalence of sleep ...
P A, van der Velden, W, Maat
openaire +2 more sources
We agree with the authors’ recommendation on the need for a sleep history in the eye clinic and probably having a lower threshold for referral to sleep physicians for further sleep studies.1 However, we would like to bring to their attention other epidemiological studies where screening tools/sleep history have shown a high prevalence of sleep ...
P A, van der Velden, W, Maat
openaire +2 more sources
The Fundamentals of Uveal Melanoma
Clinical Journal of Oncology Nursing, 2009Although rare, uveal melanoma is the most common primary intraocular malignant tumor in adults. Over the past 50 years, the incidence in North America has been stable, with 4.3 per million (or about 1,500 cases per year) being newly diagnosed (Sato, Han, & Yamamoto, 2008).
openaire +2 more sources
American Journal of Ophthalmology, 1994
Because familial occurrences of uveal melanoma are rare, there have only been 15 cases of familial melanoma reported in the literature. We studied 11 additional families with a total of 24 members, in which two or more members were afflicted with uveal melanoma.
L H, Young +3 more
openaire +2 more sources
Because familial occurrences of uveal melanoma are rare, there have only been 15 cases of familial melanoma reported in the literature. We studied 11 additional families with a total of 24 members, in which two or more members were afflicted with uveal melanoma.
L H, Young +3 more
openaire +2 more sources
Melanoma Research, 2003
A new tool in the search for tumour markers is proteomic technology. Proteomics (or protein profiling) is the study of the proteome, the protein complement of the genome. The advantage of this technique in comparison with genomics is that the actual protein production can be measured.
Guy S, Missotten +3 more
openaire +2 more sources
A new tool in the search for tumour markers is proteomic technology. Proteomics (or protein profiling) is the study of the proteome, the protein complement of the genome. The advantage of this technique in comparison with genomics is that the actual protein production can be measured.
Guy S, Missotten +3 more
openaire +2 more sources
2015
Uveal melanoma (UM) comprises approximately 5 % of all melanoma diagnoses in the USA each year. Approximately half of patients with UM eventually develop metastases, most commonly involving the liver. Historically, prognosis for these patients has been poor, with death occurring 6-12 months from the time of metastases.
Alexander N, Shoushtari +1 more
openaire +2 more sources
Uveal melanoma (UM) comprises approximately 5 % of all melanoma diagnoses in the USA each year. Approximately half of patients with UM eventually develop metastases, most commonly involving the liver. Historically, prognosis for these patients has been poor, with death occurring 6-12 months from the time of metastases.
Alexander N, Shoushtari +1 more
openaire +2 more sources
2014
Many patients with uveal melanoma die as a result of systemic spread, despite successful treatment of the primary tumor. This raises important and unsettling questions about how and in whom ocular treatment influences survival, if at all. Such questions cannot be fully answered without a proper understanding of the natural history of uveal melanomas ...
Bertil E. Damato, Azzam Taktak
openaire +1 more source
Many patients with uveal melanoma die as a result of systemic spread, despite successful treatment of the primary tumor. This raises important and unsettling questions about how and in whom ocular treatment influences survival, if at all. Such questions cannot be fully answered without a proper understanding of the natural history of uveal melanomas ...
Bertil E. Damato, Azzam Taktak
openaire +1 more source